Skip to main content

Table 3 The metabolic response of supradiaphragmatic and retroperitoneal lymphnodes to neoadjuvant chemotherapy

From: Behavior of FDG-avid supradiaphragmatic lymph nodes in PET/CT throughout primary therapy in advanced serous epithelial ovarian cancer: a prospective study

  Response to first line treatment Supradiaphragmatic lymphnodes Retroperitoneal lymphnodes p value
Complete response after NACT responders 65% (39/60) 68% (23/34) 0.82
non-responders 30% (11/37) 40% (8/20) 0.55
Mean decrease in SUVmax in sdLNs with partial metabolic response responders 42% 67% 0.13
non-responders 20% 27% 0.90